Valuation: Imexpharm Corporation

Market Cap 5,49800Cr 21Cr 18Cr 17Cr 15Cr 29Cr 2TCr 30Cr 201.23Cr 79Cr 988.01Cr 79Cr 77Cr 3.41TCr P/E 2026 *
15.5x
P/E 2027 * 14.3x
Enterprise Value 5,49800Cr 21Cr 18Cr 17Cr 15Cr 29Cr 2TCr 30Cr 201.23Cr 79Cr 988.01Cr 79Cr 77Cr 3.41TCr EV / Sales 2026 *
2.07x
EV / Sales 2027 * 1.91x
Free-Float
6.42%
Yield 2026 *
2.8%
Yield 2027 * 2.8%
1 day+2.00%
1 week-0.83%
Current month-13.35%
1 month-15.10%
3 months-24.84%
6 months-33.64%
Current year-32.00%
1 week 32,650
Extreme 32650
36,000
1 month 32,650
Extreme 32650
43,150
Current year 32,650
Extreme 32650
57,000
1 year 32,650
Extreme 32650
57,000
3 years 23,681.82
Extreme 23681.8182
57,000
5 years 18,831.17
Extreme 18831.1688
57,000
10 years 12,793.53
Extreme 12793.5306
57,000
Manager TitleAgeSince
Chief Executive Officer 74 01/08/2001
Director of Finance/CFO 52 18/01/2024
Chief Operating Officer 47 -
Director TitleAgeSince
Chairman 74 01/01/1984
Director/Board Member 50 28/04/2018
Director/Board Member - 30/05/2020
Date Insider Type Main position Quantity % Market Cap.
26/09/22 Buy

Chief Executive Officer

1,40,000 0.2100%
20/07/22 Sell

Chief Executive Officer

1,00,000 0.1500%
01/04/22 Fiscal year

Chairman

50,000 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
+2.00%-0.83%-31.21%+15.99% 20Cr
-0.87%+2.94%+49.73%+163.92% 1,08900Cr
-0.45%+5.95%+59.75%+52.18% 64TCr
+0.04%+2.81%+39.67%+74.54% 47TCr
-1.69%+8.36%+38.80%+34.26% 36TCr
-0.51%+3.35%+39.00%+43.76% 30TCr
+1.50%+5.14%+21.72%+18.77% 27TCr
+0.79%+4.32%-25.07%-36.02% 23TCr
-1.39%+5.84%+28.66%+64.00% 21TCr
-1.18%+1.88%+17.43%+72.69% 17TCr
Average -0.36%+4.77%+23.85%+50.41% 37.31TCr
Weighted average by Cap. -0.68%+5.14%+39.09%+79.00%

Financials

2026 *2027 *
Net sales 2,65900Cr 10Cr 8.77Cr 8.24Cr 7.45Cr 14Cr 966.28Cr 15Cr 97Cr 38Cr 477.82Cr 38Cr 37Cr 1.65TCr 2,88100Cr 11Cr 9.51Cr 8.93Cr 8.07Cr 15Cr 1.05TCr 16Cr 105.44Cr 41Cr 517.72Cr 41Cr 40Cr 1.79TCr
Net income 39TCr 1.5Cr 1.3Cr 1.22Cr 1.1Cr 2.09Cr 143.18Cr 2.17Cr 14Cr 5.63Cr 71Cr 5.63Cr 5.52Cr 244.63Cr 43TCr 1.63Cr 1.41Cr 1.33Cr 1.2Cr 2.27Cr 155.54Cr 2.35Cr 16Cr 6.12Cr 77Cr 6.12Cr 5.99Cr 265.75Cr
Net Debt - -
Logo Imexpharm Corporation
Imexpharm Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. It is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.
Employees
1,438
Date Price Change Volume
29/26/29 ₫35,700.00 +2.00% 7,894
28/26/28 ₫35,000.00 0.00% 8,610
27/26/27 ₫35,000.00 0.00% 12,818
24/26/24 ₫35,000.00 0.00% 23,506
23/26/23 ₫35,000.00 -2.23% 13,905
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
35,700.00VND
Average target price
56,000.00VND
Spread / Average Target
+56.86%

Annual profits - Rate of surprise